|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Dec―10 |
The SARS-CoV-2 antibody-dependent enhancement façade |
Jeremia M. Coish, Lori A. MacNeil, Adam J. MacNeil |
2 |
[GO] |
2024―Nov―21 |
Production of a monoclonal antibody targeting the SARS-CoV-2 Omicron spike protein and analysis of SARS-CoV-2 Omicron mutations related to monoclonal antibody resistance |
Jinsoo Kim, Suyeon Kim, Sangkyu Park, Dongbum Kim, Minyoung Kim, Kyeongbin Baek, et al. (+5) Bo Min Kang, Ha-Eun Shin, Myeong-Heon Lee, Younghee Lee, Hyung-Joo Kwon |
3 |
[GO] |
2024―Oct―16 |
HERV-W ENV transcription in B cells predicting symptomatic COVID-19 and risk for long COVID can express a full-length protein despite stop codon in mRNA from chromosome X via a ribosome readthrough. |
Joanna Brunel, Julien Paganini, Melissa Galloux, Benjamin Charvet, Hervé Perron |
4 |
[GO] |
2024―Sep―17 |
High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination |
Rocío Rubio, Dídac Macià, Diana Barrios, Marta Vidal, Alfons Jiménez, Luis M. Molinos-Albert, et al. (+10) Natalia Díaz, Mar Canyelles, Maria Lara-Escandell, Cyril Planchais, Pere Santamaria, Carlo Carolis, Luis Izquierdo, Ruth Aguilar, Gemma Moncunill, Carlota Dobaño |
5 |
[GO] |
2024―Jun―22 |
The PDZ Domain of the E Protein in SARS-CoV Induces Carcinogenesis and Poor Prognosis in LUAD |
Shun Li, Jinxuan Wang, Xiaozhen Dai, Churong Li, Tao Li, Long Chen |
6 |
[GO] |
2024―May―15 |
Multicentric investigations of the role in the disease severity of accelerated phospholipid changes in COVID-19 patient airway. |
Christie Mitri, François Philippart, Emmanuelle Sacco, Stéphane Legriel, Nathalie Rousselet, Gabrielle Dupuis, et al. (+4) Benoît Colsch, Harriet Corvol, Lhousseine Touqui, Olivier Tabary |
7 |
[GO] |
2024―May―07 |
SARS-CoV-2 prevalence in wildlife 2020-2022: a worldwide systematic review and meta-analysis |
Xue-Yao Yang, Jing-Shu Huang, Qing-Long Gong, Jin-Mei Sun, Yan-Jin Li, Bing Liu, et al. (+5) Yu-Meng Zhang, Chun-Wei Shi, Gui-Lian Yang, Wen-Tao Yang, Chun-Feng Wang |
8 |
[GO] |
2024―Apr―24 |
A murine model of DC-SIGN humanization exhibits increased susceptibility against SARS-CoV-2 |
Yeqing Tu, Yitai Fang, Rui Zheng, Dan Lu, Xiaolan Yang, Liangyan Zhang, et al. (+5) Deyu Li, Yakun Sun, Wenjing Yu, Deyan Luo, Hui Wang |
9 |
[GO] |
2023―Nov―18 |
Middle East respiratory coronavirus (MERS-CoV) internalized by llama alveolar macrophages does not result in virus replication or induction of pro-inflammatory cytokines |
Jordi Rodon, Martin Sachse, Nigeer Te, Joaquim Segalés, Albert Bensaid, Cristina Risco, Júlia Vergara-Alert |
10 |
[GO] |
2023―Nov―08 |
Associations between host microbiome and inflammation suggest role for host microbiome in driving COVID-19 disease severity |
Rachel MacCann, Tarini Shankar Ghosh, Alejandro Abner Garcia Leon, Junhui Li, Riya Negi, Colette Gaillard, et al. (+11) Gurvin Saini, Willard Tinago, Eoin R. Feeney, Obada Yousif, Aoife G. Cotter, Eoghan de Barra, Corinna Sadlier, Peter Doran, Alan Landay, Paul W. O'Toole, Patrick W. Mallon |
11 |
[GO] |
2023―Oct―10 |
Intense P.1 (Gamma) diversification followed by rapid Delta substitution in Southern Brazil: a SARS-CoV-2 Genomic Epidemiology study |
Patrícia Aline Gröhs Ferrareze, Gabriela Betella Cybis, Luiz Felipe Valter de Oliveira, Ricardo Ariel Zimerman, Dieine Estela Bernieri Schiavon, Camila Peter, Claudia Elizabeth Thompson |
12 |
[GO] |
2023―Sep―20 |
Clinical impact of human parainfluenza virus infections before and during the COVID-19 pandemic in Southern China |
Ya Li, Ying Liang, Jiaqi Tang, Ning Li, Yihao Yang, Wenyu Guo, et al. (+4) Cheng Lin, Jinyu Wu, Yongping Lin, Qigao Chen |
13 |
[GO] |
2023―Sep―20 |
Identification of SARS-CoV-2 m6A modification sites correlate with viral pathogenicity |
Ke Liu, Ying-Zi Zhang, Hui Yin, Lu-Lu Yu, Jia-Jia Cui, Ji-Ye Yin, et al. (+2) Chen-Hui Luo, Cheng-Xian Guo |
14 |
[GO] |
2023―Jul―29 |
Uncovering the Morphological Differences Between SARS-CoV-2 and SARS-CoV Based on Transmission Electron Microscopy Images |
Bakr Ahmed Taha, Yousif Al Mashhadany, Qussay Al-Jubouri, Adawiya J. Haider, Vishal Chaudhary, Retna Apsari, Norhana Arsad |
15 |
[GO] |
2023―Jul―25 |
Adverse effect of VEGFR-2 (rs1870377) polymorphism on the clinical course of COVID-19 in females and males in an age-dependent manner |
Derya Beyza SAYIN KOCAKAP, Sedat KAYGUSUZ, Emel AKSOY, Ömer ŞAHİN, Ayşe BAÇÇIOĞLU, Aydanur EKİCİ, et al. (+8) Ayşe Füsun KALPAKLIOĞLU, Mehmet Savaş EKİCİ, Serdar GÜL, Birgül KAÇMAZ, Ergin AYAŞLIOĞLU AÇIKGÖZ, Sibel ALYILMAZ BEKMEZ, Barry T. ROUSE, Ahmet Kürşat AZKUR |
16 |
[GO] |
2023―Jul―01 |
COVID-19 patients with high TNF/IFN-γ levels show hallmarks of PANoptosis, an inflammatory cell death |
Yadira Palacios, Lucero A. Ramón-Luing, Andy Ruiz, Alicia García-Martínez, Anahí Sánchez-Monciváis, Omar Barreto-Rodríguez, et al. (+5) Ramces Falfán-Valencia, Gloria Pérez-Rubio, Karen Medina-Quero, Ivette Buendia-Roldan, Leslie Chavez-Galan |
17 |
[GO] |
2023―Jun―12 |
A systematical association analysis of 25 common virus infection and genetic susceptibility of COVID-19 infection |
Na Zhang, Yujing Chen, Chun'e Li, Xiaoyue Qin, Dan He, Wenming Wei, et al. (+7) Yijing Zhao, Qingqing Cai, Sirong Shi, Xiaoge Chu, Yan Wen, Yumeng Jia, Feng Zhang |
18 |
[GO] |
2023―May―02 |
The mechanism of immune dysregulation caused by porcine reproductive and respiratory syndrome virus (PRRSV) |
Marek Sinkora, Miroslav Toman, Katerina Stepanova, Hana Stepanova, Lenka Leva, Jana Sinkorova, et al. (+14) Romana Moutelikova, Jiri Salat, Dagmar Srutkova, Martin Schwarzer, Simon Sinkora, Helena Kupcova Skalnikova, Katerina Nechvatalova, Tomas Hudcovic, Petra Hermanova, Sarka Pfeiferova, Mirka Kratochvilova, Lenka Kavanova, Blanka Dusankova, Marek Sinkora |
19 |
[GO] |
2023―Apr―19 |
Mice Humanized for MHC and hACE2 with High Permissiveness to SARS-CoV-2 Omicron Replication |
Fabien Le Chevalier, Pierre Authié, Sébastien Chardenoux, Maryline Bourgine, Benjamin Vesin, Delphine Cussigh, et al. (+12) Yohann Sassier, Ingrid Fert, Amandine Noirat, Kirill Nemirov, François Anna, Marion Bérard, Françoise Guinet, David Hardy, Pierre Charneau, François Lemonnier, Francina Langa-Vives, Laleh Majlessi |
20 |
[GO] |
2023―Jan―19 |
Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy |
Isabel Hodl, Clarissa Sallegger, Patrick Forstner, Nazanin Sareban, Martina Moritz, Barbara Dreo, et al. (+14) Eduard Schulz, Angelika Lackner, Barbara Kleinhappl, Stefan Hatzl, Florentine Moazedi-Fürst, Thomas Seifert-Held, Bettina Heschl, Michael Khalil, Christian Enzinger, Hildegard Greinix, Martin H. Stradner, Ivo Steinmetz, Peter Schlenke, Johannes Fessler |
21 |
[GO] |
2023―Jan―16 |
Salmonella-mediated oral delivery of multiple-target vaccine constructs with conserved and variable regions of SARS-CoV-2 protect against the Delta and Omicron variants in hamster |
Khristine Kaith S. Lloren, Vijayakumar Jawalagatti, Chamith Hewawaduge, Chandran Sivasankar, Ji-Young Park, John Hwa Lee |
22 |
[GO] |
2022―Dec―17 |
Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19 |
Mohadeseh Hasanpourghadi, Mikhail Novikov, Robert Ambrose, Arezki Chekaoui, Dakota Newman, Jianyi Ding, et al. (+6) Wynetta Giles-Davis, Zhiquan Xiang, Xiang Yang Zhou, Qin Liu, Kar Swagata, Hildegund CJ. Ertl |
23 |
[GO] |
2022―Dec―07 |
Association of complement pathways with COVID-19 severity and outcomes |
Kishor Devalaraja-Narashimha, Peter J. Ehmann, Cong Huang, Qin Ruan, Matthew F. Wipperman, Theodore Kaplan, et al. (+10) Chien Liu, Simisola Afolayan, David Glass, Scott Mellis, George D. Yancopoulos, Jennifer D. Hamilton, Scott MacDonnell, Sara C. Hamon, Anita Boyapati, Lori Morton |
24 |
[GO] |
2022―Nov―23 |
Can the triumph of mRNA vaccines against COVID-19 be extended to other viral infections of humans and domesticated animals? |
Sharvan Sehrawat, Nikolaus Osterrieder, D.Scott Schmid, Barry T. Rouse |
25 |
[GO] |
2022―Nov―16 |
SARS-CoV-2 neutralizing antibody response in vaccinated and non-vaccinated hospital healthcare workers with or without history of infection |
Damien Jacot, Urs von Rotz, Céline Pellaton, Fanny Blondet, Oriane Aebischer, Matthieu Perreau, et al. (+4) Mikael De Rham, Giuseppe Pantaleo, Oscar Marchetti, Gilbert Greub |
26 |
[GO] |
2022―Oct―12 |
Mycobiome profiling of nasopharyngeal region of SARS-CoV-2 infected individuals |
Abhishek Gupta, Shivang Bhanushali, Rajesh Karyakarte, Suvarna Joshi, Rashmita Das, Yogesh Shouche, Avinash Sharma |
27 |
[GO] |
2022―Sep―09 |
Factors influencing neutralizing antibody titers elicited by coronavirus disease 2019 vaccines |
Yu-An Kung, Sheng-Yu Huang, Chung-Guei Huang, Kuan-Ting Liu, Peng-Nien Huang, Kar-Yee Yu, et al. (+10) Shu-Li Yang, Chia-Pei Chen, Ching-Yun Cheng, Ing-Kit Lee, Shu-Min Lin, Han-Pin Chang, Yueh-Te Lin, Yen-Chin Liu, Guang-Wu Chen, Shin-Ru Shih |
28 |
[GO] |
2022―Aug―24 |
COVID-19 and Fungal Infections: A Double Debacle |
Sara Mina, Hajar Yaakoub, Cédric Annweiler, Vincent Dubée, Nicolas Papon |
29 |
[GO] |
2022―Apr―20 |
Time dependent decline of neutralizing antibody titers in COVID-19 patients from Pune, India and evidence of reinfection |
Purwa Doke, Jayshree Sachin Gothankar, Prakash Prabhakarrao Doke, Milind Madhukar Kulkarni, Kiran Kishanrao Khalate, Shubham Shrivastava, et al. (+2) Jayesh Rangrao Patil, Vidya Avinash Arankalle |
30 |
[GO] |
2022―Apr―04 |
Humoral Immune response to Comirnaty (BNT162b2) SARS-Cov2 mRNA vaccine in Thalassemia Major patients |
Emanuela Anastasi, Marco Marziali, Adele Preziosi, Elena Berardelli, Anna Annunziata Losardo, Michela Ribersani, et al. (+4) Pellegrina Pugliese, Antonella Farina, Patrizia Mancini, Antonio Angeloni |
31 |
[GO] |
2022―Feb―28 |
Miller-Fisher syndrome associated with SARS-CoV-2: a case report |
Dr L. Faulkner, Dr S. Scott, Dr NJ. Flint |
32 |
[GO] |
2022―Feb―02 |
Clinical and genomic data of sars-cov-2 detected in maternal-fetal interface during the first wave of infection in brazil |
Maria de Fátima Carvalho Ferreira, Janeth Aracely Ramirez Pavon, Amanda Colichio Bini Napoleão, Gláucia Maria Duarte Preza Figueiredo, Patricia Cristina Borges Florêncio, Rayssa Basílio dos Santos Arantes, et al. (+6) Paula Sossai Rizzo, Maria Aparecida Mazzutti Verlangieri Carmo, Luciano Nakazato, Valéria Dutra, Rosane Christine Hahn, Renata Dezengrini Slhessarenko |
33 |
[GO] |
2022―Jan―31 |
Application experience of a rapid nucleic acid detection system for COVID-19 |
Qing Ye, Dezhao Lu, Ting Zhang, Jianhua Mao, Shiqiang Shang |
34 |
[GO] |
2021―Dec―03 |
Impact of non-pharmaceutical interventions during the COVID-19 pandemic on common childhood respiratory viruses - A epidemiological study based on hospital data |
Qing Ye, Huihui Liu |
35 |
[GO] |
2021―Nov―25 |
NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity |
Saiful Amin, Salma Aktar, Md. Mijanur Rahman, Mohammed Mehadi Hassan Chowdhury |
36 |
[GO] |
2021―Sep―15 |
Phytomelatonin: a potential phytotherapeutic intervention on COVID-19-exposed individuals |
Emmanuel Sunday Okeke, Martins Obinna Ogugofor, Ndidi Ethel Nkwoemeka, Ekene John Nweze, Charles Obinwanne Okoye |
37 |
[GO] |
2021―Aug―21 |
Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types |
Abhishek Gupta, Rajesh Karyakarte, Suvarna Joshi, Rashmita Das, Kunal Jani, Yogesh Shouche, Avinash Sharma |
38 |
[GO] |
2021―Aug―19 |
The COVID-19 epidemic and other notifiable infectious diseases in China |
Bing-ke Bai, Qi-yu Jiang, Jun Hou |
39 |
[GO] |
2021―Jun―18 |
Comparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptide-based immunogen In vivo |
Naveen Yadav, Preeti Vishwakarma, Ritika Khatri, Gazala Siddqui, Amit Awasthi, Shubbir Ahmed, Sweety Samal |
40 |
[GO] |
2021―Jun―12 |
The role of sexual dimorphism in susceptibility to SARS-CoV-2 infection, disease severity, and mortality: facts, controversies and future perspectives |
Stavroula Pegiou, Elpiniki Rentzeperi, Theocharis Koufakis, Symeon Metallidis, Kalliopi Kotsa |
41 |
[GO] |
2021―Jun―11 |
Airborne infection with Covid-19? A historical look at a current controversy |
Igor J. Polianski |
42 |
[GO] |
2021―May―20 |
Development of leading first-generation vaccines against SARS-CoV-2 |
Pin-Yu Perera, Liyanage P. Perera |
43 |
[GO] |
2021―Apr―19 |
Management of COVID-19: Current Status and Future Prospects |
Md Alamgir Kabir, Rajib Ahmed, Rasheduzzaman Chowdhury, Sheikh Muhammad Asher Iqbal, Ramasamy Paulmurugan, Utkan Demirci, Waseem Asghar |
44 |
[GO] |
2021―Mar―27 |
Had COVID-19 spread in the community before the first confirmed case in Nagasaki, Japan? |
Norihito Kaku, Kenji Ota, Daisuke Sasaki, Norihiko Akamatsu, Naoki Uno, Kei Sakamoto, et al. (+5) Kosuke Kosai, Hiroo Hasegawa, Koichi Izumikawa, Hiroshi Mukae, Katsunori Yanagihara |
45 |
[GO] |
2021―Mar―20 |
“Transient plasma cell dyscrasia in COVID-19 patients linked to IL-6 triggering.” |
A. Farina, R. Labriola, C. Ialongo, M. Suppa, V. Viggiani, M. Lucarelli, et al. (+2) E. Anastasi, A. Angeloni |
46 |
[GO] |
2021―Mar―18 |
Prolonged Viral Shedding and Antibody Persistence in Patients with COVID-19 |
Fatemeh Fotouhi, Mostafa Salehi-Vaziri, Behrokh Farahmand, Ehsan Mostafavi, Mohammad Hassan Pouriayevali, Tahmineh Jalali, et al. (+9) Vahideh Mazaheri, Mona Sadat Larijani, Mahsa Tavakoli, Neda Afzali, Afsaneh Zokaei, SeyedeAtefe Hosseini, Mohamad Mahdi Mortazavipour, FaridehNiknam Oskouei, Amitis Ramezani |
47 |
[GO] |
2021―Mar―18 |
COVID-19 Vaccine Decisions: Considering the Choices and Opportunities |
Peter J. Hotez, Tasmiah Nuzhath, Timothy Callaghan, Brian Colwell |
48 |
[GO] |
2021―Mar―06 |
Bacterial and fungal co-infections among COVID-19 patients in intensive care unit |
Siyuan Yang, Mingxi Hua, Xinzhe Liu, Chunjing Du, Lin Pu, Pan Xiang, et al. (+2) Linghang Wang, Jingyuan Liu |
49 |
[GO] |
2021―Mar―02 |
Recurrence of COVID-19 after recovery ? A case series in health care workers, France |
Souheil Zayet, Pierre-Yves Royer, Lynda Toko, Alix Pierron, Vincent Gendrin, Timothée Klopfenstein |
50 |
[GO] |
2021―Feb―03 |
Personalized Stewardship and Interdisciplinarity: Key Elements of COVID-19 |
Tommaso Lupia, Silvia Corcione, Francesco G. De Rosa |
51 |
[GO] |
2021―Jan―20 |
Could targeting immunometabolism be a way to control the burden of COVID-19 infection? |
Engin Berber, Deepak Sumbria, Barry T. Rouse |
52 |
[GO] |
2021―Jan―14 |
COVID-19: Disease, or no disease? - that is the question. It’s the dose stupid! |
Sharvan Sehrawat, Barry T. Rouse |
53 |
[GO] |
2020―Nov―07 |
Digging the Rabbit Hole, COVID-19 Edition: Anti-Vaccine Themes and the Discourse Around COVID-19 |
Tara C. Smith, Dorit Rubinstein Reiss |
54 |
[GO] |
2020―Oct―14 |
SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector |
Lena Faust, Alexandra J. Zimmer, Mikashmi Kohli, Senjuti Saha, Jody Boffa, Marlon L. Bayot, et al. (+21) Ifeanyi Nsofor, Leonel Campos, Tivani Mashamba-Thompson, Rosa Herrera, Elom Emeka, Suvesh Shrestha, Cesar Ugarte-Gil, Achilles Katamba, Imran Pambudi, David Bichara, Roger I. Calderon, Namatullah Ahmadzada, Muhammad Aamir Safdar, Chaitali Nikam, Carolina dos Santos Lázari, Hamidah Hussain, Myint Myint Win, Kyaw Zin Than, Anthony Ahumibe, Brenda Waning, Madhukar Pai |
55 |
[GO] |
2020―Oct―10 |
COVID-19: comparative clinical features and outcome in 114 patients with or without pneumonia (Nord Franche-Comte Hospital, France) |
N’dri Juliette Kadiane-Oussou, Timothee Klopfenstein, Pierre-Yves Royer, Lynda Toko, Vincent Gendrin, Souheil Zayet |
56 |
[GO] |
2020―Oct―10 |
Non-synonymous Mutations of SARS-CoV-2 Leads Epitope Loss and Segregates its Variants |
Aayatti Mallick Gupta, Jaydeb Chakrabarti, Sukhendu Mandal |
57 |
[GO] |
2020―Sep―22 |
Low-impact social distancing interventions to mitigate local epidemics of SARS-CoV-2 |
Michael L. Jackson |
58 |
[GO] |
2020―Sep―19 |
Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system |
Nina Marí G.P. de Queiroz, Fabio V. Marinho, Marcelo A. Chagas, Luciana C.C. Leite, E. Jane Homan, Mariana T.Q. de Magalhães, Sergio C. Oliveira |
59 |
[GO] |
2020―Sep―07 |
Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses |
Damien Jacot, Gilbert Greub, Katia Jaton, Onya Opota |
60 |
[GO] |
2020―Sep―04 |
Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis |
Flavio De Maio, Ettore Lo Cascio, Gabriele Babini, Michela Sali, Stefano Della Longa, Bruno Tilocca, et al. (+5) Paola Roncada, Alessandro Arcovito, Maurizio Sanguinetti, Giovanni Scambia, Andrea Urbani |
61 |
[GO] |
2020―Jul―09 |
Opinion: Does the hygiene hypothesis apply to COVID-19 susceptibility? |
Sharvan Sehrawat, Barry T. Rouse |
62 |
[GO] |
2020―Jun―26 |
Coronavirus Vaccine-Associated Lung Immunopathology-What Is The Significance? |
Maria Elena Bottazzi, Ulrich Strych, Peter J. Hotez, David B. Corry |
63 |
[GO] |
2020―Jun―24 |
Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19 |
Jeremia M. Coish, Adam J. MacNeil |
64 |
[GO] |
2020―Jun―20 |
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19) |
Anne Lohse, Timothée Klopfenstein, Jean-Charles Balblanc, Pierre-Yves Royer, Marie Bossert, Vincent Gendrin, et al. (+8) Aline Charpentier, Ana-Maria Bozgan, Julio Badie, Charlotte Bourgoin, Remy Contreras, Isabelle Mazurier, Thierry Conrozier, Souheil Zayet |
65 |
[GO] |
2020―Jun―16 |
Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster |
Souheil Zayet, N’dri Juliette Kadiane-Oussou, Quentin Lepiller, Hajer Zahra, Pierre-Yves Royer, Lynda Toko, et al. (+2) Vincent Gendrin, Timothée Klopfenstein |
66 |
[GO] |
2020―May―21 |
Immunoinformatic analysis of the SARS-CoV-2 Envelope protein as a strategy to assess cross-protection against COVID-19 |
Bruno Tilocca, Alessio Soggiu, Maurizio Sanguinetti, Gabriele Babini, Flavio De Maio, Domenico Britti, et al. (+4) Alfonso Zecconi, Luigi Bonizzi, Andrea Urbani, Paola Roncada |
67 |
[GO] |
2020―May―18 |
Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study |
Zhihua Lv, Shaohua Cheng, Juan Le, Jingtao Huang, Lina Feng, Binghong Zhang, Yan Li |
68 |
[GO] |
2020―May―18 |
A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients |
Lei Liu, Wanbing Liu, Yaqiong Zheng, Xiaojing Jiang, Guomei Kou, Jinya Ding, et al. (+19) Qiongshu Wang, Qianchuan Huang, Yinjuan Ding, Wenxu Ni, Wanlei Wu, Shi Tang, Li Tan, Zhenhong Hu, Weitian Xu, Yong Zhang, Bo Zhang, Zhongzhi Tang, Xinhua Zhang, Honghua Li, Zhiguo Rao, Hui Jiang, Xingfeng Ren, Shengdian Wang, Shangen Zheng |
69 |
[GO] |
2020―May―16 |
Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency |
Shawn J. Green |
70 |
[GO] |
2020―May―13 |
Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season |
Chao Jiang, Xingang Yao, Yulin Zhao, Jianmin Wu, Pan Huang, Chunhua Pan, et al. (+2) Shuwen Liu, Chungen Pan |
71 |
[GO] |
2020―May―11 |
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development |
Cuiqing Ma, Shan Su, Jiachao Wang, Lin Wei, Lanying Du, Shibo Jiang |
72 |
[GO] |
2020―May―07 |
Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan, China |
Yan Ma, Qing-nan Xu, Feng-li Wang, Xiao-man Ma, Xiao-yan Wang, Xiao-guo Zhang, Zhong-fa Zhang |
73 |
[GO] |
2020―May―06 |
The Forrest Gump approach to preventing severe COVID-19 - reverse the predisposing pro-inflammatory state with exercise |
Chris Kenyon |
74 |
[GO] |
2020―May―06 |
Current development of COVID-19 diagnostics, vaccines and therapeutics |
Naru Zhang, Chaoqun Li, Yue Hu, Kangchen Li, Jintian Liang, Lili Wang, et al. (+2) Lanying Du, Shibo Jiang |
75 |
[GO] |
2020―May―06 |
Could nasal nitric oxide help to mitigate the severity of COVID-19? |
Jan Martel, Yun-Fei Ko, John D. Young, David M. Ojcius |
76 |
[GO] |
2020―Apr―30 |
Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes |
Mario Adán Moreno-Eutimio, Constantino López-Macías, Rodolfo Pastelin-Palacios |
77 |
[GO] |
2020―Apr―22 |
The fate of house cats during the COVID-19 pandemic |
Tianyue Gao, Xingchen Pan, Chungen Pan |
78 |
[GO] |
2020―Apr―17 |
Chloroquine Paradox May Cause More Damage Than Help Fight COVID-19 |
Anuj Sharma |
79 |
[GO] |
2020―Apr―17 |
The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement |
Peter J. Hotez, Maria Elena Bottazzi, David B. Corry |
80 |
[GO] |
2020―Apr―14 |
Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses |
Bruno Tilocca, Alessio Soggiu, Maurizio Sanguinetti, Vincenzo Musella, Domenico Britti, Luigi Bonizzi, et al. (+2) Andrea Urbani, Paola Roncada |
81 |
[GO] |
2020―Apr―08 |
Emergency response to the outbreak of COVID-19: the Korean case |
Kyoo-Man Ha |
82 |
[GO] |
2020―Apr―05 |
It is too soon to attribute ADE to COVID-19 |
Anuj Sharma |
83 |
[GO] |
2020―Mar―19 |
Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 |
Ye Qiu, Yuan-Bo Zhao, Qiong Wang, Jin-Yan Li, Zhi-Jian Zhou, Ce-Heng Liao, Xing-Yi Ge |
84 |
[GO] |
2020―Mar―17 |
Molecular basis of COVID-19 relationships in different species: a one health perspective |
Bruno Tilocca, Alessio Soggiu, Vincenzo Musella, Domenico Britti, Maurizio Sanguinetti, Andrea Urbani, Paola Roncada |
85 |
[GO] |
2020―Feb―22 |
Is COVID-19 Receiving ADE From Other Coronaviruses? |
Jason A. Tetro |
86 |
[GO] |
2020―Feb―21 |
Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases |
Xingchen Pan, David M. Ojcius, Tianyue Gao, Zhongsheng Li, Chunhua Pan, Chungen Pan |
87 |
[GO] |
2020―Feb―21 |
The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future |
Jin-Yan Li, Zhi You, Qiong Wang, Zhi-Jian Zhou, Ye Qiu, Rui Luo, Xing-Yi Ge |
88 |
[GO] |
2020―Feb―20 |
Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses |
Jieliang Chen |
89 |
[GO] |
2020―Feb―01 |
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China |
Fei Yu, Lanying Du, David M. Ojcius, Chungen Pan, Shibo Jiang |